Transfer of interferon β-1a into human breastmilk

Breastfeeding Medicine

Volumn 7, Issue 2, 2012, Pages 123-125

  Hale, Thomas W ^a   Siddiqui, Afzal A ^a   Baker, Teresa E ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BREAST FEEDING; BREAST MILK; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; DRUG MILK LEVEL; FEMALE; HUMAN; IMMUNOTHERAPY; INFANT; MALE; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADULT; BREAST FEEDING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; INTERFERON-BETA; LACTATION; MILK, HUMAN; MULTIPLE SCLEROSIS;

EID: 84859595040     PISSN: 15568253     EISSN: 15568342     Source Type: Journal    
DOI: 10.1089/bfm.2011.0044     Document Type: Article

References (5)

1. Courtney AM, Treadaway K, Remington G, et al. Multiple sclerosis. Med Clin North Am 2009;93:451-476, ix-x.
2. Munafo A, Trinchard-Lugan II, Nguyen TX, et al. Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration. Eur J Neurol 1998;5:187-193. (Pubitemid 28142571)
3. Hartung HP. High-dose, high-frequency recombinant interferon beta-1a in the treatment of multiple sclerosis. Expert Opin Pharmacother 2009;10:291-309.
4. Kumar AR, Hale TW, Mock RE. Transfer of interferon alfa into human breast milk. J Hum Lact 2000;16:226-228.
5. Kamei N, Morishita M, Chiba H, et al. Complexation hydrogels for intestinal delivery of interferon b and calcitonin. J Control Release 2009;134:98-102.